PLASMINOGEN

PLASMINOGEN Suppliers list
Company Name: Sinopharm Chemical Reagent Co,Ltd.  
Tel: 86-21-63210123
Email: sj_scrc@sinopharm.com
Company Name: Sigma-Aldrich  
Tel: 021-61415566 800-8193336
Email: orderCN@merckgroup.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 18916372613
Email: yanzihan@shyuanye.com
Company Name: Guangzhou LES biological Technology Co.,Ltd.  
Tel: 13672434928;13672434928
Email: 3307355104@qq.com
Company Name: Shanghai Jizhi Biochemical Technology Co. Ltd.  
Tel: 021-4009004166/18616739031 18616739031
Email: 3007523370@qq.com
PLASMINOGEN Basic information
Product Name:PLASMINOGEN
Synonyms:PLASMINOGEN, GLU-TYPE, HUMAN;PLASMINOGEN, GLU-TYPE, HUMAN PLASMA;PLASMINOGEN, HUMAN;PLASMINOGEN, HUMAN PLASMA;PLASMA TRYPSINOGEN, HUMAN;PROFIBRINOLYSIN;PROFIBRINOLYSIN, HUMAN;GLU-PLASMINOGEN (HUMAN)
CAS:9001-91-6
MF:NULL
MW:0
EINECS:232-641-9
Product Categories:
Mol File:Mol File
PLASMINOGEN Structure
PLASMINOGEN Chemical Properties
storage temp. -20°C
solubility water: soluble
form lyophilized powder
color White to off-white
biological sourcehuman plasma
Water Solubility water: soluble
Specific Activity7units/mg protein
Safety Information
Hazard Codes B,Xi
Risk Statements 36/37/38
Safety Statements 26-36
WGK Germany 3
F 10-21
Storage Class11 - Combustible Solids
MSDS Information
ProviderLanguage
SigmaAldrich English
PLASMINOGEN Usage And Synthesis
UsesPlasminogen is a single-chain glycoprotein found in human plasma and extracellular fluid. Certain activators, such as tissue plasminogen activator (tPA), convert plasminogen to its active form, plasmin. Plasminogen has been used to study its conversion into plasmin.
General DescriptionThe plasminogen (PLG) gene is mapped to human chromosome 6q26. Plasminogen protein has a molecular weight of 90kDa. It is composed of Pan-apple domain at the N-terminal, five kringle domains and serine protease domain at its C-terminal.
Biochem/physiol ActionsPlasminogen is the inactive precursor of the protease plasmin. Plasminogen is activated by the action of either tissue plasminogen activator (tPA), which primarily activates the fibrinolytic (thrombolytic) activity of plasmin, or urokinase plasminogen activator (uPA), which is associated with extracellular matrix remodeling and cell migration. Plasmin cleaves fibrin/fibrinogen and blood coagulation factors V/Va and VIII/VIIIa. It activates matrix metalloproteinases by cleaving the inactive proenzymes. It is also involved in the activation of some growth factors, such as vascular endothelial growth factor (VEGF) and transforming growth factor β (TGF-β).
in vivo

Plasminogen (plg) (2 mg/per; i.v.; single daily for 16 days) accelerates the healing of burn wounds in WT mice[1].
Plasminogen (plg) (2 mg/per; i.v.; single daily for 16 days) enhances the expression of IL-6 and augments the activation of STAT3 in wounded skin of both WT and plg-deficient mice[1].
Plasminogen (plg) (2 mg/per; i.v.; single daily for 24 days) improves the healing of burn wounds in a mouse model of diabetes[1].

Animal Model:WT mice (plg-heterozygous (plg+/-)) mice, plg+/- and plg-deficient (plg-/-) mice (C57BL/6 background; 8- to 10- week-old; burn-wound model)[1].
Dosage:2 mg/per
Administration:Intravenous injection; single daily for 16 days.
Result:Showed a significantly faster healing speed than control group at day 6, and the time to healing (ie, the scab falling off) was also approximately 2 days earlier than in the control group.
Promoted epithelium layer fused to reepithelialize the wound completely, and only a small scab remained lightly attached above the wound when at day 11.
Enhanced the level of IL-6 in the wounds of both WT and plg-deficient mice, and increased the pSTA T3 level in the wound.
Animal Model:Genetically diabetic mice (C57BLKS db/db; at least 10 weeks old; with a minimal blood glucose level of 15 mM) and control heterozygous littermates (C57BLKS db/+; at least 10 weeks old; with a minimal blood glucose level of 7.8 mM)[1].
Dosage:2 mg/per
Administration:Intravenous injection; single daily for 24 days.
Result:Showed time to healing (ie, the scab falling off) was significantly earlier (approximately 3 days) than the control group.
Accelerated the injured epithelium layer and the underlying tissue healed. (the front of the epithelium layer in the control group had barely fused and was covered by a scab. In addition, the tissue underneath the scab was inflamed).
PLASMINOGEN Preparation Products And Raw materials
Tag:PLASMINOGEN(9001-91-6) Related Product Information
Benzyl isocyanide Tris(2,4-pentanedionato)chroMiuM(III) SALCOMINE COBALT(II) ACETYLACETONATE Ethyl isocyanoacetate Cupric acetylacetonate Tosylmethyl isocyanide Aluminum acetylacetonate Thrombin Phenylselenol tert-Butyl isocyanide 1,1,3,3-Tetramethylbutyl isocyanide Methyl isocyanoacetate N-Butylisocyanide 2,4-Pentanedione, silver derivative Dichloro(ethylenediamine)platinum(II) Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)dysprosium(III) Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)europium(III)